The manufacturers suggest that concurrent use of reboxetine and ergot derivatives might result in increased blood pressure, although no clinical data are quoted. The general significance of this interaction is unclear.
(10)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.